Myopia

How studies into myopia management can increase access to vision care.

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary end point for slowing pediatric myopia progression.

In April 2021, WCO partnered with CooperVision to introduce its myopia management standard of care, defining evidence-based standard of care comprising of mitigation, measurement, and management.

The 6th World Congress of Optometry will be held during Saudi Society of Optometry’s 11th Optometry Conference and Exhibition.

The system aids in the orthokeratology lens design process by syncing directly with topographers to create precise lens designs for the treatment of myopia in the matter of seconds.

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

The upgraded Myopia Software Package offers comprehensive screening, ortho-k fitting, and myopia management in one device.

The study evaluated 13 teenagers and young adults who had high myopia (−6.50 to −9.25 D).

Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.

Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).

Visual acuity remains an important indication of ocular and visual health.

The 2025 Myopia Research Grant will comprise of 3 awards of $500,000 each.

From eye drops to novel treatments, it’s time to assess all options for improving patients’ visual acuity.

The updated range of lenses feature expanded negative and cylindrical powers, thinner edge thickness, and wider frame options.

The longitudinal study found that visual function and BCVA decreased with an increasing incidence rate of moderate and severe visual impairment for patients with high myopia.

Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia progressed at a rate of −0.17 D annually after switching to single-vision lenses.

With this addition, Zeiss completes the Corneal Refractive Workflow, which already includes Visumax 800 and SMILE pro.

The educational resources is now being used in 64% of the world's countries, with the US, the United Kingdom, Malaysia, India, Australia, and Canada as the most frequent users.

Model simulations conducted in part to assess net monetary benefit found that comprehensive eye examinations every 3 years were more cost effective than less frequent examinations.

Trending topics and milestone stories from our year in ophthalmology.

Key takeaways from the past year that can help optometrists look ahead to 2025.

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children.

New long-term findings illuminate the future of DIMS spectacle lenses.

Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.

A new classification system helps patients reach informed decisions.

In an AAOpt poster, Dr. Mark Bullimore investigates the definition of "normal progression" in myopic eyes and the change of efficacy over time.

Increased choroidal thickness also was seen in children treated with 1% atropine for 1 week or 0.01% atropine for less than 8 weeks.

Six topics were assessed in the report, including global data on myopia prevalence, technology, environmental and genetic contributions to myopia onset and progression, and mechanistic causes of myopia pathogenesis, among others.

Understanding and balancing digital exposure in children can reduce myopia progression.